Your browser doesn't support javascript.
loading
Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine.
Neale, Kyle J; Weimer, Melissa B; Davis, Mellar P; Jones, Katie Fitzgerald; Kullgren, Justin G; Kale, Sachin S; Childers, Julie; Broglio, Kathleen; Merlin, Jessica S; Peck, Sarah; Francis, Sheria Y; Bango, Jacqueline; Jones, Christopher A; Sager, Zachary; Ho, J Janet.
Affiliation
  • Neale KJ; The Lois U and Harry R Horvitz Palliative Medicine Program, Department of Palliative Medicine and Supportive Care, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Weimer MB; Program in Addiction Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Davis MP; Department of Palliative Care, Geisinger Medical Center, Danville, Pennsylvania, USA.
  • Jones KF; William F. Connell School of Nursing, Boston College, Chestnut Hill, Massachusetts, USA.
  • Kullgren JG; Palliative Medicine Clinical Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Kale SS; Division of Palliative Medicine, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Childers J; Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Broglio K; Section of Palliative Medicine, Geisel School of Medicine at Dartmouth, Collaboratory for Implementation Sciences at Dartmouth, Lebanon, New Hampshire, USA.
  • Merlin JS; Section of Palliative Care and Medical Ethics and Palliative Research Center, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Peck S; Division of Palliative Medicine, Emory University Healthcare Midtown, Atlanta, Georgia, USA.
  • Francis SY; Collaborative Care Management, University of Pittsburgh Medical Center Presbyterian Shadyside, Pittsburgh, Pennsylvania, USA.
  • Bango J; The Juniper Center, Chicago, Illinois, USA.
  • Jones CA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Sager Z; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ho JJ; Division of Palliative Medicine, University of California San Francisco, San Francisco, California, USA.
J Palliat Med ; 26(1): 120-130, 2023 01.
Article in En | MEDLINE | ID: mdl-36067137
ABSTRACT
Pain management in palliative care (PC) is becoming more complex as patients survive longer with life-limiting illnesses and population-wide trends involving opioid misuse become more common in serious illness. Buprenorphine, a generally safe partial mu-opioid receptor agonist, has been shown to be effective for both pain management and opioid use disorder. It is critical that PC clinicians become comfortable with indications for its use, strategies for initiation while understanding risks and benefits. This article, written by a team of PC and addiction-trained specialists, including physicians, nurse practitioners, social workers, and a pharmacist, offers 10 tips to demystify buprenorphine use in serious illness.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Hospice and Palliative Care Nursing / Opioid-Related Disorders Limits: Humans Language: En Journal: J Palliat Med Journal subject: SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Hospice and Palliative Care Nursing / Opioid-Related Disorders Limits: Humans Language: En Journal: J Palliat Med Journal subject: SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: United States